Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Moxifloxacin (Avelox)

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section
Search DailyMed products (opens in a new tab)

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Avelox ® - Moxifloxacin (opens in a new tab)Original source URL: https://globalrph.com/dilution/avelox-moxifloxacin/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/avelox-moxifloxacin/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:46:06.217271+00:00
Source location
div.post-content
Packaged content SHA-256
f08b67968cc7e2e32fd103aaa17df4598032408678777f9ade9a0e3c55d43532
Original response SHA-256
ff5d59674e43a07ec5332ba64883ee90d0bdc87040dbe2d8d3c4c9a49b7ce14b
Source body SHA-256
68ad29630b948aa7e4756cecc84ce4f6a4052f4eb8e3b433d054bcb7a62ebe62

Moxifloxacin (Avelox ®)
The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents
Not applicable - Premix Bags - 0.8% saline

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]
[ 400 mg ] [ 250 ml ] [ 1 hour ]

Premix Bags: AVELOX I.V. (moxifloxacin hydrochloride in sodium chloride injection) is available in ready-to-use 250 mL latex-free flexible bags containing 400 mg of moxifloxacin in 0.8% saline. NO FURTHER DILUTION OF THIS PREPARATION IS NECESSARY.

Stability / Miscellaneous

Stability data:
Drug Stability
Refrigerated		 Stability
Room Temp.		 Reconstituted
Vial/Powder 		Notes
Avelox - Moxifloxacin Do not refrigerate - product precipitates upon refrigeration Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) Solution


Label: DO NOT REFRIGERATE - PRODUCT PRECIPITATES UPON REFRIGERATION

AVELOX I.V. should be administered by INTRAVENOUS infusion only.

DOSAGE AND ADMINISTRATION: The dose of AVELOX is 400 mg (orally or as an intravenous infusion) once every 24 hours.

For Complicated Intra-Abdominal Infections, therapy should be initiated with the intravenous formulation. When switching from intravenous to oral dosage administration, no dosage adjustment is necessary. Patients whose therapy is started with AVELOX I.V. may be switched to AVELOX Tablets when clinically indicated at the discretion of the physician.

Infection Daily Dose Duration
Acute Bacterial Sinusitis 400 mg 10 days
Acute Bacterial Exacerbation of Chronic Bronchitis 400 mg 5 days
Community Acquired
Pneumonia		 400 mg 7-14 days
Uncomplicated Skin and Skin Structure Infections 400 mg 7 days
Complicated Skin and Skin Structure Infections 400 mg 7-21 days
Complicated Intra-Abdominal Infections 400 mg 5-14 days

Impaired Renal Function: No dosage adjustment is required in renally impaired patients, including those on either hemodialysis or continuous ambulatory peritoneal dialysis.

Separate renal reference: Open Renal Dosing Master (opens in a new tab)

Parenteral drug products should be inspected visually for particulate matter prior to administration. Samples containing visible particulates should not be used.

Since the premix flexible containers are for single-use only, any unused portion should be discarded. Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

Source: Bayer Pharmaceuticals. Avelox (moxifloxacin) [package insert]. West Haven, CT; 2007.

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
no_routine_adjustment_identified
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        class_level
        Provenance classification
        historical_class_level
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      moxifloxacin-avelox
      Source IDH51-3D66A74544572F58AC9194E2
      Generic name
      Moxifloxacin (Avelox)
      Source IDH51-732633F938EAE1599565DEC3
      Class
      Antibacterial
      Source IDH51-CCEFEAE24C937D43A43CA735
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-B62273F70C4AFC9FD55B1494
      Primary uses
      1. Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
        Source IDH51-3C3AE96577FABE5727CDDC11
      Mechanism
      Fluoroquinolone inhibition of bacterial DNA gyrase and topoisomerase IV disrupts DNA replication and repair.
      Source IDH51-A31CFBCC6FD9C07D240A1DD1
      Mechanism level
      class_level
      Source IDH51-5104CF416FE351D57631AF88
      Basic dosing orientation
      The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy.
      Source IDH51-16479B86A13C06856E6513D4
      Administration orientation
      Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required.
      Source IDH51-78D0769B6AFFBAB1FC4B2D14
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
      Source IDH51-CC45160E2368D1427BB9C8FD
      Key safety orientation
      1. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-550AB7438D73E31114F0C381
      Coverage path
      automatic_legacy_quick_reference
      Source IDH51-986DCB0F2E0B2D3C54E75692
      Coverage path label
      Automatic legacy GlobalRPh quick reference
      Source IDH51-9A5CD2E8846CC2922969D01F
      Legacy title
      Moxifloxacin (Avelox)
      Source IDH51-7A12F20AA23CF2A837AF5076
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-69420E6C8DB3426512EEA3E4
      Search text
      Moxifloxacin (Avelox) Antibacterial Legacy GlobalRPh directory entry Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use. Fluoroquinolone inhibition of bacterial DNA gyrase and topoisomerase IV disrupts DNA replication and repair. The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy. Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required. No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Automatic legacy GlobalRPh quick reference
      Source IDH51-1DAD2710F98DBED9FCE45679
      Official access mode
      search
      Source IDH51-5F2569571820E97D5AC10D70
      Official search query
      Moxifloxacin (Avelox)
      Source IDH51-C54F84EEF81710C450C5358B
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-4F75E8883018EF918E2E2F60

      No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      no_routine_adjustment_identified
      Source IDH51-D45CCF00247D591FEB4B9ED4
      Summary
      No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
      Source IDH51-6B2835EB4F16CB8C06420601
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-6F452943FF60FE9E8574A78C

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-F08BCCC652A39127B0A9E496

      Historical Stability notes

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy product stability information is not automatically equivalent to a USP <797> BUD.
        Source IDH51-8911DA5C7D73FBD3C8051F16

      Historical supplemental professional sources

      Recovered v5.1 source content; historical, awaiting current review.

      LabelUrlKind
      Source IDH51-B5C95182750511C5249E655D
      UCSF adult antimicrobial dosing, non-dialysis
      Source IDH51-9FF4ADAA51A45D6F980D4C66
      		https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)
      Source IDH51-0E376B948DA84CC3C9ED5447
      		Professional institutional guidance
      Source IDH51-2BC4A501DDE83E71DF55019C
      Source IDH51-8CE6A821EA33F980698C02A4
      UCSF antimicrobial dosing in intermittent and continuous hemodialysis
      Source IDH51-6DCBFFB53229A8A8BF34072D
      		https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)
      Source IDH51-AC6993E7263A30CD147C9F71
      		Professional institutional guidance
      Source IDH51-F71A6A88CDD43DF01D236C6B
      Source IDH51-ABF807CC88E3EF6C6289F816
      UCSF pediatric antimicrobial dosing
      Source IDH51-F4D2B4BCCCE819666374834D
      		https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-CFE4ABC70C39EE6F2AA0E373
      		Professional institutional guidance
      Source IDH51-98334DA9F8F577D4F0162CA6
      Source IDH51-C6DC232596C059ADA2F75380
      UCSF neonatal antimicrobial dosing
      Source IDH51-B69A4215804570BF48EACB7C
      		https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-CA7A1ECC822F45F2FEDA82B5
      		Professional institutional guidance
      Source IDH51-9B23D7F80ADC401244655CEA
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      moxifloxacin-avelox
      Source IDH51-632BDFD3EFC1DE0DB8142906
      Legacy title
      Moxifloxacin (Avelox)
      Source IDH51-464CABC066604F91F0973DF9
      Generic name
      Moxifloxacin (Avelox)
      Source IDH51-11A526EA9A6D6B5264015C5D
      Class
      Antibacterial
      Source IDH51-8A417807F5CB10704F5FBB45
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-08B191AD7ABEC1337CC86AAD
      Summary
      Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.
      Source IDH51-BDD383DDBE7DE8C9B005175E
      Populations
      1. Population not yet normalized
        Source IDH51-1F7B632806A7B4C4E61B91C5
      Evidence tier
      Legacy catalog - migration review required
      Source IDH51-FC7C5DA10468FF53D33317A2
      High alert
      false
      Source IDH51-5C12255249FC5DEA9EB31B7D
      Hazardous
      false
      Source IDH51-34BA867C23E43D319E5A9405
      Status
      Legacy migration
      Source IDH51-CE0D916BFAC9E41B5D18782A
      Version added
      Legacy
      Source IDH51-9E9C21214D45C3C7CBC004C1
      Sources
      LabelUrlKind
      Source IDH51-E44C8AC490A23894EA13A400
      GlobalRPh legacy IV dilution monograph
      Source IDH51-C06AE4AC5AAD82FF303FDF56
      		legacy:auto
      Source IDH51-F35A6F3316F008E14B46C259
      		Legacy
      Source IDH51-F391F05C00813371B18A885C
      Clinical release verification
      Audit version
      3.4
      Source IDH51-9E2B29844081AFDA83B7DB5A
      Audited on
      2026-08-30
      Source IDH51-F68220BBD23279A9714C70AC
      Level
      amber
      Source IDH51-D4F92EECEBD248C29DA7BF41
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-FE903D0B0880A90FF269C347
      Exact current label candidate
      false
      Source IDH51-01EE2B8882A97343680459ED
      Reference url count
      4
      Source IDH51-62441047B0ADE8CD88BC590F
      Broken reference count
      0
      Source IDH51-A5A6B358EDD537CDFA859BF1
      Point of use confirmation required
      true
      Source IDH51-E5CECF99B972FF4A110C88DF
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-FF87FCC78A79A4E1A4169D1C

      Dosing source fields

      Id
      moxifloxacin-avelox
      Source IDH51-796021246E6C958A5BC3B569
      Generic name
      Moxifloxacin (Avelox)
      Source IDH51-3270C69E66FD9E1D2EB3158B
      Coverage status
      direct_official_label_access_plus_legacy_reference
      Source IDH51-180EAB14FF9FC49269288574
      Package insert
      Query name
      Moxifloxacin
      Source IDH51-BF24BAA5FE11CA4ABA71781F
      Product and route must match
      true
      Source IDH51-2B32395802AE35A7F85CD2F6
      Live current label enabled
      false
      Source IDH51-14994C64FE10A8526E77AE81
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-CD8CD94FB713ECA76FEBA583
      Direct official label access enabled
      true
      Source IDH51-0F2AE89D9A563FB6A857F526
      Outbound server request required
      false
      Source IDH51-CF8B466050B5414C7478F4C2
      Local summary status
      not_bundled
      Source IDH51-C68F54B95C4AB55472CA9868
      Clinical review
      Locally normalized
      false
      Source IDH51-EC82A01FF126F09C8007F101
      Reviewed
      2026-08-29
      Source IDH51-765DA1E5F900367B16D0207D
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-89AEB25C1A5BA4AD16ED8544
      Clinical release verification
      Audit version
      3.4
      Source IDH51-B062A19E1C05273293D068B6
      Audited on
      2026-08-30
      Source IDH51-5E01BF0FFBF4345599EC824A
      Level
      amber
      Source IDH51-44A8073DCFF6517901DF1E33
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-0F333856A08D86C825EBBF65
      Exact current label candidate
      false
      Source IDH51-A8B4C56D6436ACFF252EA4E1
      Reference url count
      4
      Source IDH51-A401FD424F69DDD370E44506
      Broken reference count
      0
      Source IDH51-6152AA45F87991D5FCCBB8A0
      Point of use confirmation required
      true
      Source IDH51-6CDAE2DC9CDB258807ABDF39
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-FF1215E5BC674247D99B45CB
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      moxifloxacin-avelox
      Source IDH51-17D876FA0B49E8CF8EC4C4CA
      Name
      Moxifloxacin (Avelox)
      Source IDH51-CF63C2A6895974EAB6B7E8AA
      Therapeutic class
      Antibacterial
      Source IDH51-FBD2C35AC80AAE3AA964A51C
      Review version
      3.1
      Source IDH51-32AF67575593A9ECCF27C5B7
      Review date
      2026-08-30
      Source IDH51-2DA6B66FBA483D4EB170382B
      Release status
      no_released_dilution_current_label_review_required
      Source IDH51-3C048CB90AB8EFBBC3F77A3B
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-3140D5F6FCEC6E4645B6307D
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-D55927C9E92FB068914F314A
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-2DC715D0F538055C10685C22
      Reconstitution concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-797203837E4F4D792843F7AA
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-5F51E399596E4971AA58FEDF
      Appropriate standardized containers
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-AEBD0B674C71965DFF72E49C
      Adult dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-231FF6281A48BD5DA16B005C
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-0C678E85B273088EE0F69542
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-57023DF0BDFDB1F44994B77E
      Infusion time
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-69547FFF0231401B722A9B40
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-EF8D334059276269773AA1FB
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-4A77B48A7DCBFFA43B0FBB8F
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-64018925FCE1D3C4A267C64A
      Reconstitution concentration
      Primary
      not_found
      Source IDH51-5C08189DA724B9885D61A1D0
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-BCC18D4BA888FE5B9023DB1D
      Appropriate standardized containers
      Primary
      not_found
      Source IDH51-0FEE6B2E9C18C46D2A503A01
      Adult dosing range
      Primary
      not_found
      Source IDH51-1D4224D28B0EAC3D05314148
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-33ACCA2E5E0077FB772939E6
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-F22CA93CF1C72639B803543D
      Infusion time
      Primary
      not_found
      Source IDH51-F5E44DE0B092FAED5E5D3B8B
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-31BAA9948156CE8D32F26A28
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-7190EE1760F8089D8ECC2C5E
      Population applicability
      Adult
      Applicability
      not_established
      Source IDH51-2BC02EE32D67619B15933D65
      Guide generation allowed
      false
      Source IDH51-6E7C63997979A425F29E7DCB
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-B7A01625B88D88FC28BB5B07
      Guide generation allowed
      false
      Source IDH51-A004CA280D57A45309D05C30
      Neonatal
      Applicability
      supported_or_source_present
      Source IDH51-52C68B3E0A1E291940A637CA
      Guide generation allowed
      false
      Source IDH51-7E8A8C46F499D9EF392C7B2A
      Route presence
      Structured dilution
      false
      Source IDH51-80658E75029366AE7AF318F8
      Iv push
      false
      Source IDH51-A721B453FDC7B17A55CDC0B1
      Continuous infusion
      false
      Source IDH51-0740A4D45556AE26C89F759B
      Pediatric source
      true
      Source IDH51-75BC359A1F9C4313863F5E98
      Neonatal source
      true
      Source IDH51-7251A7EF3CF5EF3C5A3939F7
      Legacy reference
      Status
      not_available
      Source IDH51-722CFAA3DD043B38EF47FCCB
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-A9257D1DE33DA981BF4DDC4B
      Source files
      1. catalog.json
        Source IDH51-EB24E8655D7F337E56C3F0D8
      2. dosing.json
        Source IDH51-F8214C44CDB87D4064420810
      3. legacy-map.json
        Source IDH51-1FB7331896D6FAB64881C7BE
      4. review-queue.json
        Source IDH51-8B39A502D00AE18D8102CA50
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-2A9F3267DA45B0BD57295839
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-632BDFD3EFC1DE0DB8142906catalog.json
      /records/171/id      		Historical; current review incomplete
      H51-464CABC066604F91F0973DF9catalog.json
      /records/171/legacy_title      		Historical; current review incomplete
      H51-11A526EA9A6D6B5264015C5Dcatalog.json
      /records/171/generic_name      		Historical; current review incomplete
      H51-8A417807F5CB10704F5FBB45catalog.json
      /records/171/class      		Historical; current review incomplete
      H51-08B191AD7ABEC1337CC86AADcatalog.json
      /records/171/subclass      		Historical; current review incomplete
      H51-BDD383DDBE7DE8C9B005175Ecatalog.json
      /records/171/summary      		Historical; current review incomplete
      H51-F08BCCC652A39127B0A9E496catalog.json
      /records/171/warnings/0      		Historical; current review incomplete
      H51-8911DA5C7D73FBD3C8051F16catalog.json
      /records/171/stability_notes/0      		Historical; current review incomplete
      H51-1F7B632806A7B4C4E61B91C5catalog.json
      /records/171/populations/0      		Historical; current review incomplete
      H51-FC7C5DA10468FF53D33317A2catalog.json
      /records/171/evidence_tier      		Historical; current review incomplete
      H51-5C12255249FC5DEA9EB31B7Dcatalog.json
      /records/171/high_alert      		Historical; current review incomplete
      H51-34BA867C23E43D319E5A9405catalog.json
      /records/171/hazardous      		Historical; current review incomplete
      H51-CE0D916BFAC9E41B5D18782Acatalog.json
      /records/171/status      		Historical; current review incomplete
      H51-E49EC95DB03E3AE1AF2B0665catalog.json
      /records/171/reviewed      		Historical; current review incomplete
      H51-9E9C21214D45C3C7CBC004C1catalog.json
      /records/171/version_added      		Historical; current review incomplete
      H51-E44C8AC490A23894EA13A400catalog.json
      /records/171/sources/0      		Historical; current review incomplete
      H51-C06AE4AC5AAD82FF303FDF56catalog.json
      /records/171/sources/0/label      		Historical; current review incomplete
      H51-F35A6F3316F008E14B46C259catalog.json
      /records/171/sources/0/url      		Historical; current review incomplete
      H51-F391F05C00813371B18A885Ccatalog.json
      /records/171/sources/0/kind      		Historical; current review incomplete
      H51-9E2B29844081AFDA83B7DB5Acatalog.json
      /records/171/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-F68220BBD23279A9714C70ACcatalog.json
      /records/171/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-D4F92EECEBD248C29DA7BF41catalog.json
      /records/171/clinical_release_verification/level      		Historical; current review incomplete
      H51-FE903D0B0880A90FF269C347catalog.json
      /records/171/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-01EE2B8882A97343680459EDcatalog.json
      /records/171/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-61D050EEED7EEF210441BAE5catalog.json
      /records/171/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-D97EFF89E86BB47C380331C8catalog.json
      /records/171/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-72CBD8477954D2A5A7DA58EFcatalog.json
      /records/171/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-62441047B0ADE8CD88BC590Fcatalog.json
      /records/171/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-A5A6B358EDD537CDFA859BF1catalog.json
      /records/171/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-E5CECF99B972FF4A110C88DFcatalog.json
      /records/171/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-FF87FCC78A79A4E1A4169D1Ccatalog.json
      /records/171/clinical_release_verification/note      		Historical; current review incomplete
      H51-958C48B843C402A908FEA4E6catalog.json
      /records/171/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-796021246E6C958A5BC3B569dosing.json
      /records/171/id      		Historical; current review incomplete
      H51-3270C69E66FD9E1D2EB3158Bdosing.json
      /records/171/generic_name      		Historical; current review incomplete
      H51-180EAB14FF9FC49269288574dosing.json
      /records/171/coverage_status      		Historical; current review incomplete
      H51-BF24BAA5FE11CA4ABA71781Fdosing.json
      /records/171/package_insert/query_name      		Historical; current review incomplete
      H51-A048656699C6F1DD3CDC232Fdosing.json
      /records/171/package_insert/preferred_setid      		Historical; current review incomplete
      H51-2B32395802AE35A7F85CD2F6dosing.json
      /records/171/package_insert/product_and_route_must_match      		Historical; current review incomplete
      H51-14994C64FE10A8526E77AE81dosing.json
      /records/171/package_insert/live_current_label_enabled      		Historical; current review incomplete
      H51-CD8CD94FB713ECA76FEBA583dosing.json
      /records/171/package_insert/source_priority      		Historical; current review incomplete
      H51-0F2AE89D9A563FB6A857F526dosing.json
      /records/171/package_insert/direct_official_label_access_enabled      		Historical; current review incomplete
      H51-CF8B466050B5414C7478F4C2dosing.json
      /records/171/package_insert/outbound_server_request_required      		Historical; current review incomplete
      H51-C68F54B95C4AB55472CA9868dosing.json
      /records/171/package_insert/local_summary_status      		Historical; current review incomplete
      H51-D45CCF00247D591FEB4B9ED4dosing.json
      /records/171/renal/classification      		Historical; current review incomplete
      H51-6B2835EB4F16CB8C06420601dosing.json
      /records/171/renal/summary      		Historical; current review incomplete
      H51-6F452943FF60FE9E8574A78Cdosing.json
      /records/171/renal/method_note      		Historical; current review incomplete
      H51-B5C95182750511C5249E655Ddosing.json
      /records/171/professional_sources/0      		Historical; current review incomplete
      H51-9FF4ADAA51A45D6F980D4C66dosing.json
      /records/171/professional_sources/0/label      		Historical; current review incomplete
      H51-0E376B948DA84CC3C9ED5447dosing.json
      /records/171/professional_sources/0/url      		Historical; current review incomplete
      H51-2BC4A501DDE83E71DF55019Cdosing.json
      /records/171/professional_sources/0/kind      		Historical; current review incomplete
      H51-8CE6A821EA33F980698C02A4dosing.json
      /records/171/professional_sources/1      		Historical; current review incomplete
      H51-6DCBFFB53229A8A8BF34072Ddosing.json
      /records/171/professional_sources/1/label      		Historical; current review incomplete
      H51-AC6993E7263A30CD147C9F71dosing.json
      /records/171/professional_sources/1/url      		Historical; current review incomplete
      H51-F71A6A88CDD43DF01D236C6Bdosing.json
      /records/171/professional_sources/1/kind      		Historical; current review incomplete
      H51-ABF807CC88E3EF6C6289F816dosing.json
      /records/171/professional_sources/2      		Historical; current review incomplete
      H51-F4D2B4BCCCE819666374834Ddosing.json
      /records/171/professional_sources/2/label      		Historical; current review incomplete
      H51-CFE4ABC70C39EE6F2AA0E373dosing.json
      /records/171/professional_sources/2/url      		Historical; current review incomplete
      H51-98334DA9F8F577D4F0162CA6dosing.json
      /records/171/professional_sources/2/kind      		Historical; current review incomplete
      H51-C6DC232596C059ADA2F75380dosing.json
      /records/171/professional_sources/3      		Historical; current review incomplete
      H51-B69A4215804570BF48EACB7Cdosing.json
      /records/171/professional_sources/3/label      		Historical; current review incomplete
      H51-CA7A1ECC822F45F2FEDA82B5dosing.json
      /records/171/professional_sources/3/url      		Historical; current review incomplete
      H51-9B23D7F80ADC401244655CEAdosing.json
      /records/171/professional_sources/3/kind      		Historical; current review incomplete
      H51-EC82A01FF126F09C8007F101dosing.json
      /records/171/clinical_review/locally_normalized      		Historical; current review incomplete
      H51-765DA1E5F900367B16D0207Ddosing.json
      /records/171/clinical_review/reviewed      		Historical; current review incomplete
      H51-89AEB25C1A5BA4AD16ED8544dosing.json
      /records/171/clinical_review/status      		Historical; current review incomplete
      H51-B062A19E1C05273293D068B6dosing.json
      /records/171/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-5E01BF0FFBF4345599EC824Adosing.json
      /records/171/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-44A8073DCFF6517901DF1E33dosing.json
      /records/171/clinical_release_verification/level      		Historical; current review incomplete
      H51-0F333856A08D86C825EBBF65dosing.json
      /records/171/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-A8B4C56D6436ACFF252EA4E1dosing.json
      /records/171/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-D987C6E2BBA5E81D0926378Ddosing.json
      /records/171/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-AFFC5793C8C084495BD63B62dosing.json
      /records/171/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-810236BE1BCCEBEDD52DC28Bdosing.json
      /records/171/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-A401FD424F69DDD370E44506dosing.json
      /records/171/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-6152AA45F87991D5FCCBB8A0dosing.json
      /records/171/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-6CDAE2DC9CDB258807ABDF39dosing.json
      /records/171/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-FF1215E5BC674247D99B45CBdosing.json
      /records/171/clinical_release_verification/note      		Historical; current review incomplete
      H51-AAA41C78BD65E6F0D8788D6Edosing.json
      /records/171/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-3D66A74544572F58AC9194E2first-look-v5.1.json
      /records/171/id      		Historical; current review incomplete
      H51-732633F938EAE1599565DEC3first-look-v5.1.json
      /records/171/generic_name      		Historical; current review incomplete
      H51-CCEFEAE24C937D43A43CA735first-look-v5.1.json
      /records/171/class      		Historical; current review incomplete
      H51-B62273F70C4AFC9FD55B1494first-look-v5.1.json
      /records/171/subclass      		Historical; current review incomplete
      H51-3C3AE96577FABE5727CDDC11first-look-v5.1.json
      /records/171/primary_uses/0      		Historical; current review incomplete
      H51-A31CFBCC6FD9C07D240A1DD1first-look-v5.1.json
      /records/171/mechanism      		Historical; current review incomplete
      H51-5104CF416FE351D57631AF88first-look-v5.1.json
      /records/171/mechanism_level      		Historical; current review incomplete
      H51-16479B86A13C06856E6513D4first-look-v5.1.json
      /records/171/basic_dosing_orientation      		Historical; current review incomplete
      H51-78D0769B6AFFBAB1FC4B2D14first-look-v5.1.json
      /records/171/administration_orientation      		Historical; current review incomplete
      H51-CC45160E2368D1427BB9C8FDfirst-look-v5.1.json
      /records/171/renal_and_population_orientation      		Historical; current review incomplete
      H51-550AB7438D73E31114F0C381first-look-v5.1.json
      /records/171/key_safety_orientation/0      		Historical; current review incomplete
      H51-986DCB0F2E0B2D3C54E75692first-look-v5.1.json
      /records/171/coverage_path      		Historical; current review incomplete
      H51-9A5CD2E8846CC2922969D01Ffirst-look-v5.1.json
      /records/171/coverage_path_label      		Historical; current review incomplete
      H51-7E029DDD1E7180018B6A9568first-look-v5.1.json
      /records/171/official_label_url      		Historical; current review incomplete
      H51-7A12F20AA23CF2A837AF5076first-look-v5.1.json
      /records/171/legacy_title      		Historical; current review incomplete
      H51-69420E6C8DB3426512EEA3E4first-look-v5.1.json
      /records/171/review_note      		Historical; current review incomplete
      H51-1DAD2710F98DBED9FCE45679first-look-v5.1.json
      /records/171/search_text      		Historical; current review incomplete
      H51-585232D81DF5D831FEBA26A4first-look-v5.1.json
      /records/171/official_search_url      		Historical; current review incomplete
      H51-5F2569571820E97D5AC10D70first-look-v5.1.json
      /records/171/official_access_mode      		Historical; current review incomplete
      H51-D33E220D4634A23A8462125Ffirst-look-v5.1.json
      /records/171/official_access_url      		Historical; current review incomplete
      H51-C54F84EEF81710C450C5358Bfirst-look-v5.1.json
      /records/171/official_search_query      		Historical; current review incomplete
      H51-4F75E8883018EF918E2E2F60first-look-v5.1.json
      /records/171/official_access_reason      		Historical; current review incomplete
      H51-17D876FA0B49E8CF8EC4C4CApreparation-assessments-v3.8.json
      /171/id      		Historical; current review incomplete
      H51-CF63C2A6895974EAB6B7E8AApreparation-assessments-v3.8.json
      /171/name      		Historical; current review incomplete
      H51-E5E99F7D1F595516510EBB28preparation-assessments-v3.8.json
      /171/brands      		Historical; current review incomplete
      H51-FBD2C35AC80AAE3AA964A51Cpreparation-assessments-v3.8.json
      /171/therapeutic_class      		Historical; current review incomplete
      H51-32AF67575593A9ECCF27C5B7preparation-assessments-v3.8.json
      /171/review_version      		Historical; current review incomplete
      H51-2DA6B66FBA483D4EB170382Bpreparation-assessments-v3.8.json
      /171/review_date      		Historical; current review incomplete
      H51-3C048CB90AB8EFBBC3F77A3Bpreparation-assessments-v3.8.json
      /171/release_status      		Historical; current review incomplete
      H51-3140D5F6FCEC6E4645B6307Dpreparation-assessments-v3.8.json
      /171/market_status/status      		Historical; current review incomplete
      H51-D55927C9E92FB068914F314Apreparation-assessments-v3.8.json
      /171/market_status/basis      		Historical; current review incomplete
      H51-2DC715D0F538055C10685C22preparation-assessments-v3.8.json
      /171/ten_point_assessment/exact_formulation      		Historical; current review incomplete
      H51-797203837E4F4D792843F7AApreparation-assessments-v3.8.json
      /171/ten_point_assessment/reconstitution_concentration      		Historical; current review incomplete
      H51-5F51E399596E4971AA58FEDFpreparation-assessments-v3.8.json
      /171/ten_point_assessment/maximum_or_recommended_final_concentration      		Historical; current review incomplete
      H51-AEBD0B674C71965DFF72E49Cpreparation-assessments-v3.8.json
      /171/ten_point_assessment/appropriate_standardized_containers      		Historical; current review incomplete
      H51-231FF6281A48BD5DA16B005Cpreparation-assessments-v3.8.json
      /171/ten_point_assessment/adult_dosing_range      		Historical; current review incomplete
      H51-0C678E85B273088EE0F69542preparation-assessments-v3.8.json
      /171/ten_point_assessment/pediatric_dosing_range      		Historical; current review incomplete
      H51-57023DF0BDFDB1F44994B77Epreparation-assessments-v3.8.json
      /171/ten_point_assessment/neonatal_dosing_range      		Historical; current review incomplete
      H51-69547FFF0231401B722A9B40preparation-assessments-v3.8.json
      /171/ten_point_assessment/infusion_time      		Historical; current review incomplete
      H51-EF8D334059276269773AA1FBpreparation-assessments-v3.8.json
      /171/ten_point_assessment/fluid_restriction_alternatives      		Historical; current review incomplete
      H51-CE154108D6B283C4A65D7A72preparation-assessments-v3.8.json
      /171/ten_point_assessment/current_manufacturer_labeling/setid      		Historical; current review incomplete
      H51-BD9898D8DBD246A6D83D516Fpreparation-assessments-v3.8.json
      /171/ten_point_assessment/current_manufacturer_labeling/title      		Historical; current review incomplete
      H51-3065F86E5FBE3EF2D27E05A9preparation-assessments-v3.8.json
      /171/ten_point_assessment/current_manufacturer_labeling/published_date      		Historical; current review incomplete
      H51-DBE9322F2D92D7A8D88D592Dpreparation-assessments-v3.8.json
      /171/ten_point_assessment/current_manufacturer_labeling/manufacturer      		Historical; current review incomplete
      H51-4A77B48A7DCBFFA43B0FBB8Fpreparation-assessments-v3.8.json
      /171/ten_point_assessment/current_manufacturer_labeling/match_confidence      		Historical; current review incomplete
      H51-B431E59535D1D354A8115FC5preparation-assessments-v3.8.json
      /171/ten_point_assessment/current_manufacturer_labeling/url      		Historical; current review incomplete
      H51-64018925FCE1D3C4A267C64Apreparation-assessments-v3.8.json
      /171/field_provenance/exact_formulation/primary      		Historical; current review incomplete
      H51-5C08189DA724B9885D61A1D0preparation-assessments-v3.8.json
      /171/field_provenance/reconstitution_concentration/primary      		Historical; current review incomplete
      H51-BCC18D4BA888FE5B9023DB1Dpreparation-assessments-v3.8.json
      /171/field_provenance/maximum_or_recommended_final_concentration/primary      		Historical; current review incomplete
      H51-0FEE6B2E9C18C46D2A503A01preparation-assessments-v3.8.json
      /171/field_provenance/appropriate_standardized_containers/primary      		Historical; current review incomplete
      H51-1D4224D28B0EAC3D05314148preparation-assessments-v3.8.json
      /171/field_provenance/adult_dosing_range/primary      		Historical; current review incomplete
      H51-33ACCA2E5E0077FB772939E6preparation-assessments-v3.8.json
      /171/field_provenance/pediatric_dosing_range/primary      		Historical; current review incomplete
      H51-F22CA93CF1C72639B803543Dpreparation-assessments-v3.8.json
      /171/field_provenance/neonatal_dosing_range/primary      		Historical; current review incomplete
      H51-F5E44DE0B092FAED5E5D3B8Bpreparation-assessments-v3.8.json
      /171/field_provenance/infusion_time/primary      		Historical; current review incomplete
      H51-31BAA9948156CE8D32F26A28preparation-assessments-v3.8.json
      /171/field_provenance/fluid_restriction_alternatives/primary      		Historical; current review incomplete
      H51-7190EE1760F8089D8ECC2C5Epreparation-assessments-v3.8.json
      /171/field_provenance/current_manufacturer_labeling/primary      		Historical; current review incomplete
      H51-2BC02EE32D67619B15933D65preparation-assessments-v3.8.json
      /171/population_applicability/adult/applicability      		Historical; current review incomplete
      H51-6E7C63997979A425F29E7DCBpreparation-assessments-v3.8.json
      /171/population_applicability/adult/guide_generation_allowed      		Historical; current review incomplete
      H51-B7A01625B88D88FC28BB5B07preparation-assessments-v3.8.json
      /171/population_applicability/pediatric/applicability      		Historical; current review incomplete
      H51-A004CA280D57A45309D05C30preparation-assessments-v3.8.json
      /171/population_applicability/pediatric/guide_generation_allowed      		Historical; current review incomplete
      H51-52C68B3E0A1E291940A637CApreparation-assessments-v3.8.json
      /171/population_applicability/neonatal/applicability      		Historical; current review incomplete
      H51-7E8A8C46F499D9EF392C7B2Apreparation-assessments-v3.8.json
      /171/population_applicability/neonatal/guide_generation_allowed      		Historical; current review incomplete
      H51-80658E75029366AE7AF318F8preparation-assessments-v3.8.json
      /171/route_presence/structured_dilution      		Historical; current review incomplete
      H51-A721B453FDC7B17A55CDC0B1preparation-assessments-v3.8.json
      /171/route_presence/iv_push      		Historical; current review incomplete
      H51-0740A4D45556AE26C89F759Bpreparation-assessments-v3.8.json
      /171/route_presence/continuous_infusion      		Historical; current review incomplete
      H51-75BC359A1F9C4313863F5E98preparation-assessments-v3.8.json
      /171/route_presence/pediatric_source      		Historical; current review incomplete
      H51-7251A7EF3CF5EF3C5A3939F7preparation-assessments-v3.8.json
      /171/route_presence/neonatal_source      		Historical; current review incomplete
      H51-722CFAA3DD043B38EF47FCCBpreparation-assessments-v3.8.json
      /171/legacy_reference/status      		Historical; current review incomplete
      H51-A9257D1DE33DA981BF4DDC4Bpreparation-assessments-v3.8.json
      /171/label_resolution/status      		Historical; current review incomplete
      H51-EB24E8655D7F337E56C3F0D8preparation-assessments-v3.8.json
      /171/source_files/0      		Historical; current review incomplete
      H51-F8214C44CDB87D4064420810preparation-assessments-v3.8.json
      /171/source_files/1      		Historical; current review incomplete
      H51-1FB7331896D6FAB64881C7BEpreparation-assessments-v3.8.json
      /171/source_files/2      		Historical; current review incomplete
      H51-8B39A502D00AE18D8102CA50preparation-assessments-v3.8.json
      /171/source_files/3      		Historical; current review incomplete
      H51-2A9F3267DA45B0BD57295839preparation-assessments-v3.8.json
      /171/clinical_release_note      		Historical; current review incomplete

      Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)

      All medicationsReturn to medication headingApplication top